SAN - Sanofi SA - Stock Price & Dividends
Exchange: Euronext Paris • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0000120578
Vaccines, Medicines, Skincare, Pain Relievers, Diabetes Treatments, Oncology Drugs
Sanofi SA is a global healthcare company that focuses on researching, developing, manufacturing, and marketing a wide range of therapeutic solutions. The company operates through three main segments: Pharmaceuticals, Vaccines, and Consumer Healthcare, catering to diverse patient needs across the United States, Europe, Canada, and international markets.
Sanofi's Pharmaceuticals segment offers specialty care solutions, including DUPIXENT, a treatment for moderate-to-severe atopic dermatitis, as well as medicines for neurology and immunology, rare diseases, oncology, and rare blood disorders. The company also provides treatments for diabetes and cardiovascular diseases, along with established prescription products.
The Vaccines segment develops and commercializes a broad portfolio of vaccines, including pediatric vaccines for poliomyelitis, pertussis, and hib, as well as influenza, booster, meningitis, and travel and endemic vaccines. This includes vaccines for hepatitis A, typhoid, cholera, yellow fever, and rabies.
Sanofi's Consumer Healthcare segment offers a range of products for cough, cold, and flu, allergy, and pain care, as well as physical, mental, and digestive wellness products. The company also provides skincare products for various needs, including itching, hydration, aging, cracking, overnight, and specialty skincare for conditions like eczema.
Sanofi has established various collaborations and agreements with other companies to drive innovation and development in the healthcare industry. These partnerships include agreements with Exscientia, ABL Bio, Blackstone Life Sciences, Seagen Inc., IGM Biosciences, Skyhawk Therapeutics, Adagene Inc., Scribe Therapeutics, and Provention Bio, among others. These collaborations focus on developing novel small-molecule therapies, antibody-drug conjugates, and genome editing technologies, among other areas.
Founded in 1994, Sanofi was previously known as Sanofi-Aventis before changing its name in May 2011. The company is headquartered in Paris, France, and is committed to improving the lives of patients worldwide through its innovative healthcare solutions. For more information, visit their website at https://www.sanofi.com.
Drawdown (Underwater) Chart
SAN Stock Overview
Market Cap in USD | 135,337m |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
GiC SubIndustry | Pharmaceuticals |
TER | 0.00% |
IPO / Inception |
SAN Stock Ratings
Growth 5y | 56.2 |
Fundamental | 35.1 |
Dividend | 65.8 |
Rel. Performance vs Sector | -0.29 |
Analysts | - |
Fair Price Momentum | 99.76 EUR |
Fair Price DCF | 81.25 EUR |
SAN Dividends
Dividend Yield 12m | 3.90% |
Yield on Cost 5y | 5.48% |
Dividends CAGR 5y | 3.01% |
Payout Consistency | 99.8% |
SAN Growth Ratios
Growth Correlation 3m | -10.7% |
Growth Correlation 12m | 85% |
Growth Correlation 5y | 81.8% |
CAGR 5y | 6.93% |
CAGR/Mean DD 5y | 0.85 |
Sharpe Ratio 12m | 0.76 |
Alpha vs SP500 12m | 3.52 |
Beta vs SP500 5y weekly | 0.33 |
ValueRay RSI | 10.51 |
Volatility GJR Garch 1y | 20.76% |
Price / SMA 50 | -5.07% |
Price / SMA 200 | 4.74% |
Current Volume | 1353.9k |
Average Volume 20d | 1387.2k |
External Links for SAN Stock
As of November 08, 2024, the stock is trading at EUR 96.52 with a total of 1,353,852 shares traded.
Over the past week, the price has changed by -3.52%, over one month by -4.30%, over three months by +2.41% and over the past year by +18.35%.
According to ValueRays Forecast Model, SAN Sanofi SA will be worth about 107.7 in November 2025. The stock is currently trading at 96.52. This means that the stock has a potential upside of +11.62%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 106.9 | 10.8 |
Analysts Target Price | - | - |
ValueRay Target Price | 107.7 | 11.6 |